Evidence map›Paper›PMID 39966210›Full record

ArticleEuropean radiology experimental2025

Cer-ConvN3Unet: an end-to-end multi-parametric MRI-based pipeline for automated detection and segmentation of cervical cancer.

Shao-Jun Xia, Bo Zhao, Yingming Li, Xiangxing Kong, Zhi-Nan Wang, Qingmo Yang, Jia-Qi Wu, Haijiao Li, Kun Cao, Hai-Tao Zhu and 3 more

Abstract readMulticenter Study
In one paragraph

Article in European radiology experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shao-Jun Xia *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Bo Zhao *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Yingming Li *Department of Radiology, Peking University People's Hospital, Beijing, China.
Xiangxing KongKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China.
Zhi-Nan WangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Qingmo YangPeking University School and Hospital of Stomatology, Beijing, China.
Jia-Qi WuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Haijiao LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Kun CaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Hai-Tao ZhuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Xiao-Ting LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Xiao-Yan ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China. 370493077@qq.com.
Ying-Shi SunKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China. sys27@163.com.ORCID http://orcid.org/0000-0001-9424-1910

Funding

Capital's Funds for Health Improvement and Research 2024-1-1022National Key R&D Program of China 2023YFC3402805Science Foundation of Peking University Cancer Hospital XKFZ2403
6 · The paper itself

Abstract

backgroundWe established and validated an innovative two-phase pipeline for automated detection and segmentation on multi-parametric cervical cancer magnetic resonance imaging (MRI) and investigated the clinical efficacy.

methodsThe retrospective multicenter study included 125 cervical cancer patients enrolled in two hospitals for 14,547 two-dimensional images. All the patients underwent pelvic MRI examinations consisting of diffusion-weighted imaging (DWI), T2-weighted imaging (T2WI), and contrast-enhanced T1-weighted imaging (CE-T1WI). The deep learning framework involved a multiparametric detection module utilizing ConvNeXt blocks and a subsequent segmentation module utilizing 3-channel DoubleU-Nets. The pipeline was trained and tested (80:20 ratio) on 3,077 DWI, 2,990 T2WI, and 8,480 CE-T1WI slices.

resultsIn terms of reference standards from gynecologic radiologists, the first automated detection module achieved overall results of 93% accuracy (95% confidence interval 92-94%), 93% precision (92-94%), 93% recall (92-94%), 0.90 κ (0.89-0.91), and 0.93 F1-score (0.92-0.94). The second-stage segmentation exhibited Dice similarity coefficients and Jaccard values of 83% (81-85%) and 71% (69-74%) for DWI, 79% (75-82%), and 65% (61-69%) for T2WI, 74% (71-76%) and 59% (56-62%) for CE-T1WI.

conclusionIndependent experiments demonstrated that the pipeline could get high recognition and segmentation accuracy without human intervention, thus effectively reducing the delineation burden for radiologists and gynecologists. RELEVANCE STATEMENT: The proposed pipeline is potentially an alternative tool in imaging reading and processing cervical cancer. Meanwhile, this can serve as the basis for subsequent work related to tumor lesions. The pipeline contributes to saving the working time of radiologists and gynecologists. KEY POINTS: An AI-assisted multiparametric MRI-based pipeline can effectively support radiologists in cervical cancer evaluation. The proposed pipeline shows high recognition and segmentation performance without manual intervention. The proposed pipeline may become a promising auxiliary tool in gynecological imaging.

Indexed as

Image Interpretation, Computer-AssistedMagnetic Resonance ImagingMultiparametric Magnetic Resonance ImagingUterine Cervical NeoplasmsAdultAgedDeep LearningFemaleHumansMiddle AgedRetrospective StudiesArtificial intelligenceAutomated detection and segmentationDeep learningMagnetic resonance imagingUterine cervical neoplasms

Identifiers

PMID39966210
PMCPMC11836247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.